Finance

Lists
Why is 002020 up 4.32%?
Dive Deeper
002020:SHE
Zhejiang Jingxin Pharmaceutical Co., Ltd
CNÂ¥11.83
+4.32%
(+0.49) 1D
Sep 30, 3:04:27 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002020...
Open
CNÂ¥11.39
High
CNÂ¥11.87
Low
CNÂ¥11.36
Mkt. cap
10.19B
Avg. vol.
13.03M
Volume
0.00
Dividend
2.96%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
Jun 11, 2026
P/E ratio
13.24
52-wk high
CNÂ¥21.65
52-wk low
CNÂ¥11.11
EPS
CNÂ¥0.89
Shares outstanding
861.03M
No. of employees
4K
Open
CNÂ¥11.39
High
CNÂ¥11.87
Low
CNÂ¥11.36
Mkt. cap
10.19B
Avg. vol.
13.03M
Volume
0.00
Dividend
2.96%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
Jun 11, 2026
P/E ratio
13.24
52-wk high
CNÂ¥21.65
52-wk low
CNÂ¥11.11
EPS
CNÂ¥0.89
Shares outstanding
861.03M
No. of employees
4K
News stories
From web sources and news partners
About Zhejiang Jingxin Pharmaceutical Co., Ltd
CEO-
Employees3.73K
Founded1990
Headquarters-
SectorPharmaceutical industry
Websitejingxinpharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.03B
1.02B
923.03M
1.06B
Cost of goods sold
506.52M
540.75M
451.52M
554.56M
Cost of revenue
506.52M
540.75M
451.52M
554.56M
Research and development expenses
89.68M
93.56M
83.03M
81.74M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
220.72M
200.08M
186.30M
185.69M
Operating expense
333.83M
292.95M
280.97M
282.38M
Total operating expenses
840.35M
833.70M
732.49M
836.94M
Operating income
191.30M
187.47M
190.55M
227.21M
Other non operating income
-969.56K
1.49M
-14.07M
13.33M
EBT including unusual items
214.65M
199.41M
191.37M
221.16M
EBT excluding unusual items
206.53M
197.34M
189.61M
241.52M
Income tax expense
25.44M
14.16M
25.22M
31.36M
Effective tax rate
11.85%
7.10%
13.18%
14.18%
Other operating expenses
17.32M
5.19M
13.98M
14.51M
Net income
187.73M
182.37M
165.20M
186.42M
Net profit margin
18.20%
17.86%
17.90%
17.52%
Earnings per share
-
-
-
-
Interest and investment income
19.21M
18.40M
14.30M
24.19M
Interest expense
-1.63M
-
-1.17M
-390.99K
Net interest expenses
17.58M
18.40M
13.14M
23.80M
Depreciation and amortization charges
-
-
-
-
EBITDA
260.03M
254.25M
257.33M
293.99M
Gain or loss from assets sale
-256.69K
574.50K
-
-6.12M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps